Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Gliosarcoma 10Glioblastoma 9Carcinoma, Non-Small-Cell Lung 5Salivary Gland Neoplasms 3Astrocytoma 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Pinealoma 2Pancreatic Neoplasms 2Medulloblastoma 2Head and Neck Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma 1Rectal Neoplasms 1Radiation Injuries 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lung Neoplasms 1

Interventions

dehydroftorafur 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Platinum 1Immunoglobulin G 1Fluorouracil 1Disulfides 1Cisplatin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 × Radiotherapy, Conformal × Clear all
NCT00408694 2018-01-30

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
46 enrolled 10 charts
Head & Neck

Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡